As noted under Anemia Management, evaluating the patient for iron deficiency is a critical step in the management of CKD patients with anemia. Additionally, it is very common for patients receiving Procrit or Aranesp to develop iron deficiency during the course of their treatment due to accelerated use of existing iron stores in the process of producing new RBCs, even without blood loss.
While oral iron preparations are readily available over the counter, they are largely ineffective in maintaining adequate iron supply, and therefore intravenous iron replacement has become the treatment of choice.
Denver Nephrology provides this intravenous iron replacement (Venofer) for our CKD patients with anemia and iron deficiency at our Infusion Centers located in our patient care offices, and as with Procrit administration, bills the patient’s insurance for this service. Typically the treatment is once weekly for 5 weeks, with additional periodic supplementation as determined by blood test results.